KRAS and lung cancer: As mentioned earlier, KRAS-mutant lung cancer cells are refractory to 1,25(OH)2D3 due to perturbations in key determinants of vitamin D signaling, such as low levels of VDR and elevated expression of CYP24A1 [19].